Trial intelligence / Profile preview

Flow Quantification in the Human Airways Using Hyperpolarized Helium 3 MRI

NCT02154568Completed

Sponsor
University of Virginia
Start
Nov 2013
Primary completion
Feb 2026
Modality
Device-based Delivery
Countries
1
01

Overview

Open-label, single-arm trial of hyperpolarized helium-3, sponsored by University of Virginia. Primary endpoint: Hyperpolarized helium MRI flow velocity map at Day 1. Started Nov 2013; status: completed.

02

Drugs

hyperpolarized helium-3

Beyond the preview

Go deeper on NCT02154568.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02154568.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call